This version is for browsers with a low level of support for CSS, and is des
Home Language Selection
Home Content Area
Home Navigator
End Navigator
The Department of Thoracic Surgery at Constance Hospital, which was established in November 2008, has since March 2009 been using an innovative laser scalpel for removing metastases of malignant tumours from the lung. Dr. Thomas Kiefer, the department’s chief physician, envisages that this will open up numerous new possibilities, which at the moment are unfortunately not fully exploited at all hospitals due to lack of knowledge.
In about 30 percent of all cancer patients treated, metastases usually appear in the lung after a few years. Lung metastases usually occur in large quantities and tend to recur after treatment. It is of key importance to save as much healthy lung tissue as possible so that 30 or 40 metastases can be operated on three, four or even more times. Unlike in the past, the diagnosis of metastases is no longer a death sentence, as innovative laser technology can now remove malignant tumours in a non-invasive way. The Department of Thoracic Surgery at the Constance Hospital uses just such a method, which was first used to treat patients on 5th March 2009. The Nd:YAG laser (Neodym: yttrium-aluminium-garnet-laser) was developed by the Tuttlingen-based medical device company Gebrüder Martin.
Dr. Thomas Kiefer, chief physician in the Department of Thoracic Surgery, explained that this innovative method enables the treatment of patients who were previously considered inoperable, thereby considerably increasing their life expectancy and assuring a virtually unaltered quality of life. "The advantage for patients is that the lung tissue can be made air- and fluid-tight as very precise cuts are made," said the physician who came to Constance from the Ortenau Hospital in Offenburg where, for nine years, he coordinated the establishment of an interdisciplinary tumour centre. The new laser method means that sutures, which frequently gather the tissue, are no longer necessary. "In the past, sutures and braces needed to be placed in healthy tissue, thereby reducing the tissue surface that was available for breathing," explains Dr. Thomas Kiefer.
Modern lasers use a wavelength of 1318 nm and are specifically designed to take into account the biophysical properties of the lung. They enable the removal of a large number of metastases (more than 150) of the size of a grain of rice or a tennis ball, both from the central parenchyma or the hilus region structures without having to remove much or any lung lobe tissue or parenchyma. Deeper metastases and tumours can also be removed and the lung segments or lobes to a large degree saved. Due to resection areas that are free of blood and have a high density of fistulas, and due to the repeatability of laser treatments in the case of recurrence, there are flexible but mechanically robust coagulation zones, which enables the Pleura visceralis fissure to be used for double safety.
"The function and effect of this specific laser has been tested by our clinical partner over a period of ten years," said Uwe Ott, product manager at Gebrüder Martin GmbH & Co. KG, the company that developed the laser. As is the case with all medical applications, the method was initially tested and analysed in animal experiments before it was authorised as an alternative method to partial lung resection. According to Uwe Ott, the new laser is currently being used in approximately 60 hospitals in Germany.

Further information:
Dr. med. Thomas Kiefer
Department of Thoracic Surgery
Constance Hospital
Luisenstrasse 7
78464 Konstanz
Tel: +49 (0)7531 / 801 - 1901
E-mail: lungenzentrum(at)klinikum- konstanz.de
Home Main Navigation
End Main Navigation
Please select the database and search for your keyword
Stay up-to-date with the BIOPRO Newsletter
Our service will ensure that you are always well informed about the latest developments in the biotechnology sector in Baden-Württemberg.